The Advisory and Governance team at HemoShear Therapeutics provides strategic guidance and oversight to ensure the company meets its objectives in developing new treatments for rare metabolic disorders. Comprised of board members and advisors, the team leverages their expertise to guide decision-making, ensure regulatory compliance, and uphold corporate governance standards.
Arun Sanyal
Advisor
David Friedman
Board Member
Gerald Cox
Advisor
Gregory Enns
Advisor
H. Thomas Watkins II...
Board Member
Jerry Vockley
Advisor
John E. Reardon
Advisor
John L. Brooks III
Board Member
John Tilton
Board Member
Kathleen M. Metters
Board Member
Kimberly Chapman
Advisor
Mattias Baumgartner
Advisor
Moeen Al-Sayed
Advisor
Nicola Longo
Advisor
Robert J. Gould
Chairman
Tom Roper
Advisor
View all